Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy

Conditions

• Transfusion-dependent Beta-Thalassemia

Interventions

• OTHER: Safety and efficacy assessments

Sponsor

Genetix Biotherapeutics Inc.